News

“This milestone showcases the productivity of our collaboration with LEO Pharma, marking the final step before ARGX-112 may enter clinical development. It triggers the third of three…
Read More...

Ionis Pharmaceuticals announced that it has licensed IONIS-AZ6-2.5-LRx, or AZD2693, to AstraZeneca following advancement of the drug into development. IONIS-AZ6-2.5-LRx is designed to…
Read More...

Amgen announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I. The new plant, the first of its kind in the United…
Read More...

Alexion Pharmaceuticals and Wilson Therapeutics AB (publ) announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all…
Read More...

Lonza is opening the world’s largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies – the next…
Read More...

Halo Pharma, a rapidly growing contract development and manufacturing organization (CDMO), offers more than 30 years’ direct experience in the production of topical drug products – from…
Read More...

Bristol-Myers Squibb Company and the Harvard Fibrosis Network of the Harvard Stem Cell Institute announce a research collaboration to discover and develop potential new therapies for…
Read More...

Protagen AG and Gustave Roussy have announced the start of a collaboration to utilize Protagen’s SeroTag technology to help identify biomarkers that predict and monitor immune-related…
Read More...

Evotec AG announced a strategic collaboration with Petra Pharma Corporation. Through the collaboration, Petra will access Evotec's INDiGO platform to accelerate the development of its…
Read More...

Veracyte, Inc. announced a research collaboration through which Loxo Oncology will access Veracyte’s new Afirma Xpression Atlas platform to advance its development of highly selective…
Read More...

Lyophilization Services of New England (LSNE) announced a strategic plan to expand its Quality Control (QC) laboratory in Bedford, NH, and provide new employment opportunities for its…
Read More...

Inovio Pharmaceuticals and CEPI – the Coalition for Epidemic Preparedness Innovations – announced a partnership under which Inovio will develop vaccine candidates against Lassa fever…
Read More...

Zealand Pharma reports that it has engaged in a collaboration with Roche Diabetes Care for the Phase 3 trials with dasiglucagon for treatment of congenital hyperinsulinism (CHI).…
Read More...

Promethera Biosciences SA announced that it has acquired Baliopharm AG, a Swiss biopharmaceutical company focused on the development of targeted biological therapies for immune mediated…
Read More...

Pfizer has joined the TriNetX global health research network. As a member, Pfizer will have access to clinical data from TriNetX's network of healthcare organizations to support…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Afinitor DISPERZ (everolimus tablets for oral suspension), for the adjunctive treatment of adult and…
Read More...

Charles River Laboratories International, Inc. and PathoQuest announced an expansion of their strategic partnership agreement to provide next-generation sequencing (NGS) services to the…
Read More...

Novartis announced that it has entered into an agreement and plan of merger with AveXis, Inc. to acquire the US-based Nasdaq-listed clinical stage gene therapy company for USD 218 per…
Read More...

Protalex, Inc. announced that the Company has enrolled the first of three patients in cohort four of its U.S./U.K. Phase 1/2 trial evaluating PRTX-100 for the treatment of adults with…
Read More...

Allele Biotechnology & Pharmaceuticals Inc. has received a Tissue Bank License from the California Department of Public Health, making it the world’s first establishment to collect…
Read More...